vs
MADRIGAL PHARMACEUTICALS, INC.（MDGL）与PROCORE TECHNOLOGIES, INC.（PCOR）财务数据对比。点击上方公司名可切换其他公司
PROCORE TECHNOLOGIES, INC.的季度营收约是MADRIGAL PHARMACEUTICALS, INC.的1.1倍（$349.1M vs $321.1M），PROCORE TECHNOLOGIES, INC.净利率更高（-10.8% vs -18.2%，领先7.5%），MADRIGAL PHARMACEUTICALS, INC.同比增速更快（210.8% vs 15.6%），PROCORE TECHNOLOGIES, INC.自由现金流更多（$109.2M vs $-133.8M）
本公司是一家美国生物制药企业，成立于2002年，专注于研发新型合成胆汁酸类似物，可用于治疗原发性胆汁性胆管炎、非酒精性脂肪肝、肝硬化等慢性肝病，以及胆汁酸性腹泻等肠道疾病。
Procore Technologies是2002年成立的美国建筑管理软件即服务（SaaS）企业，总部位于加利福尼亚州卡平特里亚。公司打造的全球平台可连接建筑行业从业者，支持搭建简化工作流，统一展现建筑项目信息，覆盖任务追踪、项目流程管理、日程排期等核心功能。
MDGL vs PCOR — 直观对比
营收规模更大
PCOR
是对方的1.1倍
$321.1M
营收增速更快
MDGL
高出195.2%
15.6%
净利率更高
PCOR
高出7.5%
-18.2%
自由现金流更多
PCOR
多$243.1M
$-133.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $321.1M | $349.1M |
| 净利润 | $-58.6M | $-37.6M |
| 毛利率 | — | 80.1% |
| 营业利润率 | -18.6% | -12.3% |
| 净利率 | -18.2% | -10.8% |
| 营收同比 | 210.8% | 15.6% |
| 净利润同比 | 1.4% | 39.6% |
| 每股收益（稀释后） | $-2.55 | $-0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDGLPCOR
| Q4 25 | $321.1M | $349.1M | ||
| Q3 25 | $287.3M | $338.9M | ||
| Q2 25 | $212.8M | $323.9M | ||
| Q1 25 | $137.3M | $310.6M | ||
| Q4 24 | $103.3M | $302.0M | ||
| Q3 24 | $62.2M | $295.9M | ||
| Q2 24 | — | $284.3M | ||
| Q1 24 | $0 | $269.4M |
净利润MDGLPCOR
| Q4 25 | $-58.6M | $-37.6M | ||
| Q3 25 | $-114.2M | $-9.1M | ||
| Q2 25 | $-42.3M | $-21.1M | ||
| Q1 25 | $-73.2M | $-33.0M | ||
| Q4 24 | $-59.4M | $-62.3M | ||
| Q3 24 | $-107.0M | $-26.4M | ||
| Q2 24 | — | $-6.3M | ||
| Q1 24 | $-147.5M | $-11.0M |
毛利率MDGLPCOR
| Q4 25 | — | 80.1% | ||
| Q3 25 | — | 79.7% | ||
| Q2 25 | — | 79.1% | ||
| Q1 25 | 96.7% | 79.1% | ||
| Q4 24 | — | 81.2% | ||
| Q3 24 | — | 81.4% | ||
| Q2 24 | — | 83.1% | ||
| Q1 24 | — | 83.0% |
营业利润率MDGLPCOR
| Q4 25 | -18.6% | -12.3% | ||
| Q3 25 | -39.7% | -4.4% | ||
| Q2 25 | -22.2% | -9.3% | ||
| Q1 25 | -57.8% | -11.7% | ||
| Q4 24 | -64.8% | -21.9% | ||
| Q3 24 | -187.1% | -12.3% | ||
| Q2 24 | — | -5.2% | ||
| Q1 24 | — | -7.0% |
净利率MDGLPCOR
| Q4 25 | -18.2% | -10.8% | ||
| Q3 25 | -39.8% | -2.7% | ||
| Q2 25 | -19.9% | -6.5% | ||
| Q1 25 | -53.4% | -10.6% | ||
| Q4 24 | -57.5% | -20.6% | ||
| Q3 24 | -172.0% | -8.9% | ||
| Q2 24 | — | -2.2% | ||
| Q1 24 | — | -4.1% |
每股收益（稀释后）MDGLPCOR
| Q4 25 | $-2.55 | $-0.25 | ||
| Q3 25 | $-5.08 | $-0.06 | ||
| Q2 25 | $-1.90 | $-0.14 | ||
| Q1 25 | $-3.32 | $-0.22 | ||
| Q4 24 | $-2.50 | $-0.42 | ||
| Q3 24 | $-4.92 | $-0.18 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | $-7.38 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $198.7M | $768.5M |
| 总债务越低越好 | $339.9M | — |
| 股东权益账面价值 | $602.7M | $1.3B |
| 总资产 | $1.3B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.56× | — |
8季度趋势，按日历期对齐
现金及短期投资MDGLPCOR
| Q4 25 | $198.7M | $768.5M | ||
| Q3 25 | $295.7M | $684.0M | ||
| Q2 25 | $186.2M | $620.9M | ||
| Q1 25 | $183.6M | $566.7M | ||
| Q4 24 | $100.0M | $775.4M | ||
| Q3 24 | $232.7M | $756.9M | ||
| Q2 24 | — | $735.4M | ||
| Q1 24 | $622.5M | $744.6M |
总债务MDGLPCOR
| Q4 25 | $339.9M | — | ||
| Q3 25 | $339.8M | — | ||
| Q2 25 | $118.4M | — | ||
| Q1 25 | $118.0M | — | ||
| Q4 24 | $117.6M | — | ||
| Q3 24 | $117.1M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $116.1M | — |
股东权益MDGLPCOR
| Q4 25 | $602.7M | $1.3B | ||
| Q3 25 | $625.7M | $1.2B | ||
| Q2 25 | $696.0M | $1.2B | ||
| Q1 25 | $710.6M | $1.2B | ||
| Q4 24 | $754.4M | $1.3B | ||
| Q3 24 | $777.2M | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | $850.8M | $1.2B |
总资产MDGLPCOR
| Q4 25 | $1.3B | $2.2B | ||
| Q3 25 | $1.4B | $2.1B | ||
| Q2 25 | $1.0B | $2.0B | ||
| Q1 25 | $996.6M | $1.9B | ||
| Q4 24 | $1.0B | $2.1B | ||
| Q3 24 | $1.1B | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $1.1B | $1.9B |
负债/权益比MDGLPCOR
| Q4 25 | 0.56× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 0.17× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.15× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-133.5M | $114.9M |
| 自由现金流经营现金流 - 资本支出 | $-133.8M | $109.2M |
| 自由现金流率自由现金流/营收 | -41.7% | 31.3% |
| 资本支出强度资本支出/营收 | 0.1% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $282.2M |
8季度趋势，按日历期对齐
经营现金流MDGLPCOR
| Q4 25 | $-133.5M | $114.9M | ||
| Q3 25 | $79.8M | $88.5M | ||
| Q2 25 | $-47.1M | $30.8M | ||
| Q1 25 | $-88.9M | $66.0M | ||
| Q4 24 | $-104.5M | $29.1M | ||
| Q3 24 | $-67.0M | $39.3M | ||
| Q2 24 | — | $58.7M | ||
| Q1 24 | $-149.2M | $69.1M |
自由现金流MDGLPCOR
| Q4 25 | $-133.8M | $109.2M | ||
| Q3 25 | $79.0M | $83.1M | ||
| Q2 25 | — | $27.9M | ||
| Q1 25 | — | $62.0M | ||
| Q4 24 | $-104.7M | $17.4M | ||
| Q3 24 | $-67.8M | $35.7M | ||
| Q2 24 | — | $56.8M | ||
| Q1 24 | $-149.5M | $67.1M |
自由现金流率MDGLPCOR
| Q4 25 | -41.7% | 31.3% | ||
| Q3 25 | 27.5% | 24.5% | ||
| Q2 25 | — | 8.6% | ||
| Q1 25 | — | 20.0% | ||
| Q4 24 | -101.3% | 5.8% | ||
| Q3 24 | -109.0% | 12.1% | ||
| Q2 24 | — | 20.0% | ||
| Q1 24 | — | 24.9% |
资本支出强度MDGLPCOR
| Q4 25 | 0.1% | 1.6% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.0% | 1.3% | ||
| Q4 24 | 0.2% | 3.9% | ||
| Q3 24 | 1.3% | 1.2% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 0.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDGL
| Rebates Customer Fees Credits Co Pay Assistance And Other | $208.5M | 65% |
| Other | $76.0M | 24% |
| Chargebacks Discounts For Prompt Pay And Other Allowances | $36.6M | 11% |
PCOR
| US | $298.3M | 85% |
| Non Us | $50.9M | 15% |
